Thors L

References (3)

Title : Supplemental treatment to atropine improves the efficacy to reverse nerve agent induced bronchoconstriction - Wigenstam_2022_Chem.Biol.Interact__110061
Author(s) : Wigenstam E , Artursson E , Bucht A , Thors L
Ref : Chemico-Biological Interactions , :110061 , 2022
Abstract : Wigenstam_2022_Chem.Biol.Interact__110061
ESTHER : Wigenstam_2022_Chem.Biol.Interact__110061
PubMedSearch : Wigenstam_2022_Chem.Biol.Interact__110061
PubMedID: 35872047

Title : Efficacy of atropine and scopolamine on airway contractions following exposure to the nerve agent VX - Wigenstam_2021_Toxicol.Appl.Pharmacol__115512
Author(s) : Wigenstam E , Forsberg E , Bucht A , Thors L
Ref : Toxicol Appl Pharmacol , :115512 , 2021
Abstract : Wigenstam_2021_Toxicol.Appl.Pharmacol__115512
ESTHER : Wigenstam_2021_Toxicol.Appl.Pharmacol__115512
PubMedSearch : Wigenstam_2021_Toxicol.Appl.Pharmacol__115512
PubMedID: 33785355

Title : Efficient agent degradation within skin is important for decontamination of percutaneously exposed VX - Thors_2021_Cutan.Ocul.Toxicol__1
Author(s) : Thors L , Wigenstam E , Qvarnstrom J , Bucht A
Ref : Cutan Ocul Toxicol , :1 , 2021
Abstract : Thors_2021_Cutan.Ocul.Toxicol__1
ESTHER : Thors_2021_Cutan.Ocul.Toxicol__1
PubMedSearch : Thors_2021_Cutan.Ocul.Toxicol__1
PubMedID: 33759679